Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics

Despite global efforts, it took 7 months between the proclamation of global SARS-CoV-2 pandemic and the first FDA-approved treatment for COVID-19. During this timeframe, clinicians focused their efforts on repurposing drugs, such as hydroxychloroquine (HCQ) or azithromycin (AZM) to treat hospitalize...

Descripción completa

Detalles Bibliográficos
Autores principales: Charrez, Bérénice, Charwat, Verena, Siemons, Brian A., Goswami, Ishan, Sakolish, Courtney, Luo, Yu-Syuan, Finsberg, Henrik, Edwards, Andrew G., Miller, Evan W., Rusyn, Ivan, Healy, Kevin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378272/
https://www.ncbi.nlm.nih.gov/pubmed/34421592
http://dx.doi.org/10.3389/fphar.2021.684252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378272/
https://www.ncbi.nlm.nih.gov/pubmed/34421592
http://dx.doi.org/10.3389/fphar.2021.684252

Ejemplares similares